Healthcare Services

A key trend shaping the AI In Cancer Diagnostics Market Global Report 2026 Market involves the AI-Driven Pathology Solutions Transform Cancer Diagnosis in Europe

March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The AI In Cancer Diagnostics Market Expected To Change Between 2026 And 2030?

The market for AI in cancer diagnostics has seen rapid expansion over the last few years. This market is projected to expand from $0.79 billion in 2025 to reach $0.96 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 20.2%. Historically, its expansion has been driven by factors such as the initial limited integration of AI in early diagnostic processes, a previous dependence on conventional imaging methods, a global increase in cancer cases, a growing need for solutions that enable early detection, and an increase in the number of diagnostic centers.

The ai in cancer diagnostics market size is projected to experience significant expansion in the coming years, with an anticipated valuation of $1.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 19.9%. This growth throughout the forecast period is driven by advancements in deep learning and machine learning algorithms, the proliferation of ai-powered imaging systems, increasing integration of predictive analytics in healthcare, rising investments in digital health technologies, and enhanced collaboration between ai developers and medical institutions. Prominent trends for this period include the growing adoption of AI-based imaging and diagnostic tools, the incorporation of predictive analytics into cancer screening, the increased application of ai for tumor identification and classification, the expansion of AI-driven monitoring and follow-up systems, and strengthened cooperation between hospitals and ai solution providers.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp

What Underlying Factors Are Accelerating The Growth Of The AI In Cancer Diagnostics Market?

The rising incidence of cancer is expected to drive the expansion of artificial intelligence in the cancer diagnostics market. Cancer involves a cluster of diseases characterized by abnormal cell proliferation with the capacity to invade or spread to other parts of the body. Integrating AI into cancer care aims to enhance efficiency, accuracy, and personalized treatment options, ultimately improving patient outcomes. For instance, in May 2024, the National Cancer Institute, a US-based Government agency, projected approximately 2 million new cancer cases to be diagnosed in the U.S. in 2024, with over 611,000 deaths anticipated. By 2040, new cancer cases globally are estimated to increase to 29.9 million, alongside a rise in cancer-related deaths to 15.3 million. Therefore, the increasing prevalence of cancer is a significant driver for the growth of artificial intelligence in the cancer diagnostics market.

How Is The AI In Cancer Diagnostics Market Structured Across Different Segments?

The ai in cancer diagnostics market covered in this report is segmented –

1) By Component: Software Solutions, Hardware, Services

2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes

Subsegments:

1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software

2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices

3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

Which Trends Are Shaping The Future Of The AI In Cancer Diagnostics Market?

Leading companies in the AI in cancer diagnostics market are witnessing substantial growth, propelled by innovations in AI-driven digital pathology systems for identifying cancer. These AI-powered digital pathology solutions for cancer detection involve the application of artificial intelligence algorithms to identify cancer and other diagnostic indicators across various tissue types, thereby facilitating accurate and prompt cancer diagnoses, assisting in case prioritization, and ensuring consistent diagnostic outcomes. For example, in November 2023, Dedalus and Ibex Medical Analytics, a European health software company, introduced an integrated end-to-end AI-powered digital pathology system for cancer diagnosis across Europe. This particular solution seeks to enhance accuracy, provide AI-enabled decision support tools, simplify reporting, improve laboratory efficiency, and elevate diagnostic certainty.

Which Major Players Dominate The AI In Cancer Diagnostics Market?

Major companies operating in the ai in cancer diagnostics market are Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Kheiron Medical Technologies Limited, CureMetrix Inc, CancerIQ Inc, MultiplAI Health Inc, Freenome Holdings Inc, SkinVision B V, Owkin Inc, Imagen Technologies Inc, Cyrcadia Health Inc, Oncora Medical Inc, Xilis Inc

Read the full ai in cancer diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Which Region Is Projected To Dominate The AI In Cancer Diagnostics Market During The Forecast Period?

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored AI In Cancer Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13567&type=smp

Browse Through More Reports Similar to the Global AI In Cancer Diagnostics Market 2026, By The Business Research Company

artificial intelligence in cancer diagnostics global market report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

AI in medical diagnostics global market report

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

artificial intelligence in the diagnostic global market report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795